MSD for Mothers 1 is committed to supporting efforts to reduce maternal mortality globally. We collaborate across sectors — working with NGOs, professional associations, entrepreneurs, UN agencies, research institutions, governments and other companies – to address leading causes of maternal mortality and support countries in their efforts to strengthen health systems.
Our collaborative approach is undertaken with the goal of improving access to quality maternal health care, including access to quality medicines, and has been informed by consensus recommendations from the United Nations Commission on Life Saving Commodities for Women and Children 2 .
As the number one driver of maternal mortality, especially in low- and middle-income countries, MSD for Mothers has taken a comprehensive approach to addressing postpartum hemorrhage, or excessive bleeding after childbirth. Our efforts to address postpartum hemorrhage are informed by a health system strengthening approach and identifying possible solutions to challenges through human centered design 3,4,5,6 . Our aim is to identify, support and advance evidence-based practices for effectively, safely and sustainably introducing new solutions as part of routine standard of care and in accordance with guidelines.
We have invested in new innovations 7 and research including clinical trials 8,9,10 , studies to assess the quality of medicines 11 , research on uterotonic use at country level 12 and the translation of normative recommendations into policy 13 and practice in support of safe and appropriate adoption of solutions to prevent postpartum hemorrhage into health care delivery systems. Our collaborations have focused on:
Health inequities are often exacerbated by the inability to access quality-assured medicines. MSD for Mothers is investing in country-level implementation research and supporting processes to build capacity of local institutions to introduce innovations 23,24 and enhance decision making around the use of new medicines, including cost-effectiveness studies, and exploring the challenges and potential solutions to support safe introduction.
At a global level, we prioritize shared learning, supporting global conferences and workshops and disseminating evidence on the experiences of our collaborators - most recently through our support of a supplement in International Journal of Gynecology & Obstetrics on postpartum hemorrhage prevention and management 25 .
These investments in addressing postpartum hemorrhage are a key part of MSD for Mothers broader strategy to improve the quality of maternal health care 26 .
1 MSD for Mothers, known as Merck for Mothers in the United States and Canada, is an initiative of Merck & Co., Inc., Rahway, NJ, U.S.A.
2 UN Commission on Life-Saving Commodities for Women and Children
7 Profile of the Jada ® System: the vacuum-induced hemorrhage control device for treating abnormal postpartum uterine bleeding and postpartum hemorrhage